{"id":4480,"date":"2018-12-19T10:53:14","date_gmt":"2018-12-19T09:53:14","guid":{"rendered":"https:\/\/colox.ch\/?p=4480"},"modified":"2019-01-10T09:13:32","modified_gmt":"2019-01-10T08:13:32","slug":"pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde","status":"publish","type":"post","link":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/","title":{"rendered":"PME Magazine \u00ab\u00a0Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\u00a0\u00bb"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">Avec 1700 d\u00e9c\u00e8s par ann\u00e9e, soit pr\u00e8s de 5 personnes chaque jour, le cancer du c\u00f4lon est l\u2019un des cancers les plus meurtriers en Suisse. Pour Novigenix, la d\u00e9tection pr\u00e9coce joue un r\u00f4le cl\u00e9. \u00abLa maladie peut mettre une dizaine d\u2019ann\u00e9es avant que le patient en ressente les sympt\u00f4mes, explique Brian Hashemi, son pr\u00e9sident. Or, plus elle est d\u00e9cel\u00e9e t\u00f4t, plus les chances de gu\u00e9rison sont \u00e9lev\u00e9es.\u00bb Aujourd\u2019hui, moins de 40% de la population de 50 ans et plus est \u00e0 jour avec le d\u00e9pistage du cancer du c\u00f4lon. La jeune soci\u00e9t\u00e9, n\u00e9e en 2014 suite \u00e0 un management buy-out, entend bien \u00e9lever cette proportion gr\u00e2ce \u00e0 son test baptis\u00e9 <a href=\"https:\/\/colox.ch\/colox\/\">Colox<\/a><\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"p1\"><span class=\"s1\">Commercialis\u00e9 depuis trois ans, notamment via les laboratoires <a href=\"https:\/\/unilabs.ch\/fr\">Unilabs<\/a> et Dr <a href=\"https:\/\/www.risch.ch\/de\/home\">Risch<\/a>, ce test sanguin permet de d\u00e9terminer la pr\u00e9sence de l\u00e9sions colorectales canc\u00e9reuses et pr\u00e9-canc\u00e9reuses via la mesure de la r\u00e9ponse immunitaire de l\u2019h\u00f4te. Une approche commode et efficace dont l\u2019objectif est d\u2019identifier les patients qui ont vraiment besoin d\u2019une coloscopie. \u00abLe grand avantage de notre approche, c\u2019est qu\u2019elle peut facilement s\u2019int\u00e9grer dans une routine m\u00e9dicale, chez le m\u00e9decin de famille par exemple\u00bb, ajoute Nicolas Demierre, COO de Novigenix. A ce jour, 3500 tests Colox ont \u00e9t\u00e9 effectu\u00e9s en Suisse au travers de 400 m\u00e9decins.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"p1\"><span class=\"s1\">Il reste toutefois encore du chemin \u00e0 parcourir avant d\u2019obtenir son remboursement par l\u2019Office f\u00e9d\u00e9ral de la sant\u00e9 publique. Un objectif que Novigenix et sa dizaine de collaborateurs esp\u00e8rent atteindre avec la deuxi\u00e8me g\u00e9n\u00e9ration de Colox, qui fait l\u2019objet d\u2019une nouvelle \u00e9tude clinique men\u00e9e aupr\u00e8s de 1600 personnes en bonne sant\u00e9 et souffrant du cancer colorectal. Les r\u00e9sultats devraient \u00eatre connus d\u2019ici 18 \u00e0 24 mois. \u00abLe s\u00e9quen\u00e7age haut d\u00e9bit du transcriptome des cellules immunitaires et l\u2019intelligence artificielle offrent de nouvelles possibilit\u00e9s qui n\u2019existaient pas il y a dix ans. Aujourd\u2019hui, il est possible d\u2019\u00e9tudier 16\u00a0000 g\u00e8nes\u00bb, rel\u00e8ve Brian Hashemi.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"p1\"><span class=\"s1\">De quoi permettre \u00e0 la jeune pousse du Biop\u00f4le d\u2019Epalinges de \u00abd\u00e9velopper le meilleur test sanguin \u00e0 l\u2019\u00e9chelon mondial, estime le pr\u00e9sident de Novigenix. Et d\u2019appliquer dans le futur cette approche \u00e0 la d\u00e9tection pr\u00e9coce d\u2019autres cancers.\u00bb C\u00f4t\u00e9 chiffres, la soci\u00e9t\u00e9 a lanc\u00e9 un tour de financement de 10 millions de francs aupr\u00e8s d\u2019investisseurs. 4 millions ont \u00e9t\u00e9 r\u00e9colt\u00e9s \u00e0 ce jour. Novigenix, qui a nou\u00e9 des partenariats strat\u00e9giques en Chine notamment, entend lancer une IPO \u00e0 l\u2019horizon 2022.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Source: <a href=\"https:\/\/www.pme.ch\/entreprises\/2018\/12\/20\/novigenix-veut-developper-meilleur-test-sanguin-monde\">PME Magazine<\/a> | Elisabeth Kim<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Avec 1700 d\u00e9c\u00e8s par ann\u00e9e, soit pr\u00e8s de 5 personnes chaque jour, le cancer du c\u00f4lon est l\u2019un des cancers les plus meurtriers en Suisse. Pour Novigenix, la d\u00e9tection pr\u00e9coce joue un r\u00f4le cl\u00e9. \u00abLa maladie peut mettre une dizaine d\u2019ann\u00e9es avant que le patient en ressente les sympt\u00f4mes, explique Brian Hashemi, son pr\u00e9sident. Or, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4481,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[70,71],"class_list":["post-4480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-pme-magazine","tag-test-sanguin"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PME Magazine &quot;Novigenix veut d\u00e9velopper le meilleur test sanguin du monde&quot; - Colox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PME Magazine &quot;Novigenix veut d\u00e9velopper le meilleur test sanguin du monde&quot; - Colox\" \/>\n<meta property=\"og:description\" content=\"Avec 1700 d\u00e9c\u00e8s par ann\u00e9e, soit pr\u00e8s de 5 personnes chaque jour, le cancer du c\u00f4lon est l\u2019un des cancers les plus meurtriers en Suisse. Pour Novigenix, la d\u00e9tection pr\u00e9coce joue un r\u00f4le cl\u00e9. \u00abLa maladie peut mettre une dizaine d\u2019ann\u00e9es avant que le patient en ressente les sympt\u00f4mes, explique Brian Hashemi, son pr\u00e9sident. Or, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\" \/>\n<meta property=\"og:site_name\" content=\"Colox\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-19T09:53:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-10T08:13:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1181\" \/>\n\t<meta property=\"og:image:height\" content=\"1227\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicolas Demierre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Demierre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\"},\"author\":{\"name\":\"Nicolas Demierre\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/6c3d7bdab24ae49fe6aa2dbfb4789232\"},\"headline\":\"PME Magazine \u00ab\u00a0Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\u00a0\u00bb\",\"datePublished\":\"2018-12-19T09:53:14+00:00\",\"dateModified\":\"2019-01-10T08:13:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\"},\"wordCount\":468,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/colox.ch\/de\/#organization\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg\",\"keywords\":[\"PME Magazine\",\"test sanguin\"],\"articleSection\":[\"News Novigenix\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\",\"url\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\",\"name\":\"PME Magazine \\\"Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\\\" - Colox\",\"isPartOf\":{\"@id\":\"https:\/\/colox.ch\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg\",\"datePublished\":\"2018-12-19T09:53:14+00:00\",\"dateModified\":\"2019-01-10T08:13:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage\",\"url\":\"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg\",\"contentUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg\",\"width\":1181,\"height\":1227},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/colox.ch\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PME Magazine \u00ab\u00a0Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\u00a0\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/colox.ch\/de\/#website\",\"url\":\"https:\/\/colox.ch\/de\/\",\"name\":\"Colox\",\"description\":\"The new generation blood test\",\"publisher\":{\"@id\":\"https:\/\/colox.ch\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/colox.ch\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/colox.ch\/de\/#organization\",\"name\":\"Novigenix SA\",\"url\":\"https:\/\/colox.ch\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png\",\"contentUrl\":\"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png\",\"width\":700,\"height\":297,\"caption\":\"Novigenix SA\"},\"image\":{\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/6c3d7bdab24ae49fe6aa2dbfb4789232\",\"name\":\"Nicolas Demierre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/colox.ch\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/10\/Nicolas-Demmi\u00e8re_avatar-96x96.jpg\",\"contentUrl\":\"https:\/\/colox.ch\/wp-content\/uploads\/2017\/10\/Nicolas-Demmi\u00e8re_avatar-96x96.jpg\",\"caption\":\"Nicolas Demierre\"},\"description\":\"Dr. Nicolas Demierre is the Chief Operating Officer focusing on operations, business development, and engagement of strategic partners. Nicolas holds a PhD in Applied Sciences and an Executive MBA degree from HEC. Prior to joining Novigenix Nicolas was head of sales and business development at Mycartis, a spinoff of Biocartis.\",\"sameAs\":[\"https:\/\/colox.ch\"],\"url\":\"https:\/\/colox.ch\/fr\/author\/nicolas\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PME Magazine \"Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\" - Colox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/","og_locale":"fr_FR","og_type":"article","og_title":"PME Magazine \"Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\" - Colox","og_description":"Avec 1700 d\u00e9c\u00e8s par ann\u00e9e, soit pr\u00e8s de 5 personnes chaque jour, le cancer du c\u00f4lon est l\u2019un des cancers les plus meurtriers en Suisse. Pour Novigenix, la d\u00e9tection pr\u00e9coce joue un r\u00f4le cl\u00e9. \u00abLa maladie peut mettre une dizaine d\u2019ann\u00e9es avant que le patient en ressente les sympt\u00f4mes, explique Brian Hashemi, son pr\u00e9sident. Or, [&hellip;]","og_url":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/","og_site_name":"Colox","article_published_time":"2018-12-19T09:53:14+00:00","article_modified_time":"2019-01-10T08:13:32+00:00","og_image":[{"width":1181,"height":1227,"url":"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg","type":"image\/jpeg"}],"author":"Nicolas Demierre","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Nicolas Demierre","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#article","isPartOf":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/"},"author":{"name":"Nicolas Demierre","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/6c3d7bdab24ae49fe6aa2dbfb4789232"},"headline":"PME Magazine \u00ab\u00a0Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\u00a0\u00bb","datePublished":"2018-12-19T09:53:14+00:00","dateModified":"2019-01-10T08:13:32+00:00","mainEntityOfPage":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/"},"wordCount":468,"commentCount":0,"publisher":{"@id":"https:\/\/colox.ch\/de\/#organization"},"image":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage"},"thumbnailUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg","keywords":["PME Magazine","test sanguin"],"articleSection":["News Novigenix"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/","url":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/","name":"PME Magazine \"Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\" - Colox","isPartOf":{"@id":"https:\/\/colox.ch\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage"},"image":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage"},"thumbnailUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg","datePublished":"2018-12-19T09:53:14+00:00","dateModified":"2019-01-10T08:13:32+00:00","breadcrumb":{"@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#primaryimage","url":"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg","contentUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2018\/12\/novigenix-PME-magazine_november-2018.jpg","width":1181,"height":1227},{"@type":"BreadcrumbList","@id":"https:\/\/colox.ch\/fr\/pme-magazine-novigenix-veut-developper-le-meilleur-test-sanguin-du-monde\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/colox.ch\/"},{"@type":"ListItem","position":2,"name":"PME Magazine \u00ab\u00a0Novigenix veut d\u00e9velopper le meilleur test sanguin du monde\u00a0\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/colox.ch\/de\/#website","url":"https:\/\/colox.ch\/de\/","name":"Colox","description":"The new generation blood test","publisher":{"@id":"https:\/\/colox.ch\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/colox.ch\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/colox.ch\/de\/#organization","name":"Novigenix SA","url":"https:\/\/colox.ch\/de\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/","url":"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png","contentUrl":"http:\/\/colox.ch\/wp-content\/uploads\/2017\/04\/logo_novigenix-negatif-700px-2.png","width":700,"height":297,"caption":"Novigenix SA"},"image":{"@id":"https:\/\/colox.ch\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/6c3d7bdab24ae49fe6aa2dbfb4789232","name":"Nicolas Demierre","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/colox.ch\/de\/#\/schema\/person\/image\/","url":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/10\/Nicolas-Demmi\u00e8re_avatar-96x96.jpg","contentUrl":"https:\/\/colox.ch\/wp-content\/uploads\/2017\/10\/Nicolas-Demmi\u00e8re_avatar-96x96.jpg","caption":"Nicolas Demierre"},"description":"Dr. Nicolas Demierre is the Chief Operating Officer focusing on operations, business development, and engagement of strategic partners. Nicolas holds a PhD in Applied Sciences and an Executive MBA degree from HEC. Prior to joining Novigenix Nicolas was head of sales and business development at Mycartis, a spinoff of Biocartis.","sameAs":["https:\/\/colox.ch"],"url":"https:\/\/colox.ch\/fr\/author\/nicolas\/"}]}},"_links":{"self":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts\/4480"}],"collection":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/comments?post=4480"}],"version-history":[{"count":0,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/posts\/4480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/media\/4481"}],"wp:attachment":[{"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/media?parent=4480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/categories?post=4480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colox.ch\/fr\/wp-json\/wp\/v2\/tags?post=4480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}